Neurohormonal activation in heart failure with reduced ejection fraction (original) (raw)

• Mann, D. L. Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ. Res. 116, 1254–1268 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Rouleau, J. L. et al. Activation of neurohumoral systems following acute myocardial infarction. Am. J. Cardiol. 68, 80D–86D (1991).
  Article CAS PubMed Google Scholar
• Packer, M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J. Am. Coll. Cardiol. 20, 248–254 (1992).
  Article CAS PubMed Google Scholar
• Piepoli, M. et al. Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. Circulation 93, 940–952 (1996).
  Article CAS PubMed Google Scholar
• Giannoni, A. et al. Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure. J. Am. Coll. Cardiol. 53, 1975–1980 (2009).
  Article PubMed Google Scholar
• Ponikowski, P. P. et al. Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation 104, 2324–2330 (2001).
  Article CAS PubMed Google Scholar
• Floras, J. S. & Ponikowski, P. The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction. Eur. Heart J. 36, 1974–1982 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Florea, V. G. & Cohn, J. N. The autonomic nervous system and heart failure. Circ. Res. 114, 1815–1826 (2014).
  Article CAS PubMed Google Scholar
• Sigurdsson, A. & Swedberg, K. The role of neurohormonal activation in chronic heart failure and postmyocardial infarction. Am. Heart J. 132, 229–234 (1996).
  Article CAS PubMed Google Scholar
• Cohn, J. N. et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311, 819–823 (1984).
  Article CAS PubMed Google Scholar
• Dzau, V. J., Colucci, W. S., Hollenberg, N. K. & Williams, G. H. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 63, 645–651 (1981).
  Article CAS PubMed Google Scholar
• Francis, G. S. et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 82, 1724–1729 (1990).
  Article CAS PubMed Google Scholar
• Mann, D. L., Kent, R. L., Parsons, B. & Cooper, G. I. V. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85, 790–804 (1992).
  Article CAS PubMed Google Scholar
• Adams, J. W. et al. Enhanced Gαq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc. Natl Acad. Sci. USA 95, 10140–10145 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Bisognano, J. D. et al. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. J. Mol. Cell Cardiol. 32, 817–830 (2000).
  Article CAS PubMed Google Scholar
• Engelhardt, S., Hein, L., Wiesmann, F. & Lohse, M. J. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc. Natl Acad. Sci. USA 96, 7059–7064 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Bozkurt, B. et al. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97, 1382–1391 (1998).
  Article CAS PubMed Google Scholar
• Teerlink, J. R., Pfeffer, J. M. & Pfeffer, M. A. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ. Res. 75, 105–113 (1994).
  Article CAS PubMed Google Scholar
• Cohn, J. N. et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N. Engl. J. Med. 325, 303–310 (1991).
  Article CAS PubMed Google Scholar
• Packer, M. et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N. Engl. J. Med. 334, 1350–1355 (1996).
  Article Google Scholar
• Pitt, B. et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med. 341, 709–717 (1999).
  Article CAS PubMed Google Scholar
• The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N. Engl. J. Med. 325, 293 (1991).
• MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353, 2001–2007 (1999).
• Bristow, M. R. et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 94, 2807–2816 (1996).
  Article CAS PubMed Google Scholar
• Yancy, C. W. et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 15, e147–e239 (2013).
  Article Google Scholar
• Notarius, C. F., Millar, P. J. & Floras, J. S. Muscle sympathetic activity in resting and exercising humans with and without heart failure. Appl. Physiol. Nutr. Metab. 40, 1107–1115 (2015).
  Article PubMed Google Scholar
• Weinberger, M. H., Aoi, W. & Henry, D. P. Direct effect of beta-adrenergic stimulation on renin release by the rat kidney slice in vitro. Circ. Res. 37, 318–324 (1975).
  Article CAS PubMed Google Scholar
• Bekheirnia, M. R. & Schrier, R. W. Pathophysiology of water and sodium retention: edematous states with normal kidney function. Curr. Opin. Pharmacol. 6, 202–207 (2006).
  Article CAS PubMed Google Scholar
• McCollum, L. T., Gallagher, P. E. & Ann Tallant, E. Angiotensin-(1–7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1. Am. J. Physiol. Heart Circ. Physiol. 302, H801–H810 (2012).
  Article CAS PubMed Google Scholar
• Wamberg, C., Plovsing, R. R., Sandgaard, N. C. & Bie, P. Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R971–980 (2003).
  Article CAS PubMed Google Scholar
• Huang, B. S. et al. Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction. Cardiovasc. Res. 97, 424–431 (2013).
  Article CAS PubMed Google Scholar
• Esteban, V. et al. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells. Circ. Res. 96, 965–973 (2005).
  Article CAS PubMed Google Scholar
• Bomback, A. S. & Klemmer, P. J. The incidence and implications of aldosterone breakthrough. Nat. Clin. Pract. Nephrol. 3, 486–492 (2007).
  Article CAS PubMed Google Scholar
• Schrier, R. W. Aldosterone 'escape' versus 'breakthrough'. Nat. Rev. Nephrol. 6, 61 (2010).
  Article PubMed Google Scholar
• Pitt, B., Remme, W. & Zannad, F. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309–1321 (2003).
  Article CAS PubMed Google Scholar
• Braunwald, E. The path to an angiotensin receptor antagonist-neprilysin inhibitor in the treatment of heart failure. J. Am. Coll. Cardiol. 65, 1029–1041 (2015).
  Article CAS PubMed Google Scholar
• Schrier, R. W. & Abraham, W. T. Hormones and hemodynamics in heart failure. N. Engl. J. Med. 341, 577–585 (1999).
  Article CAS PubMed Google Scholar
• Clerico, A., Recchia, F. A., Passino, C. & Emdin, M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am. J. Physiol. Heart Circ. Physiol. 290, H17–H29 (2006).
  Article CAS PubMed Google Scholar
• Volpe, M., Carnovali, M. & Mastromarino, V. The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clin. Sci. (Lond.) 130, 57–77 (2016).
  Article CAS Google Scholar
• McMurray, J. J. et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N. Engl. J. Med. 317, 993–1004 (2014).
  Article CAS Google Scholar
• Shah, A. M. & Mann, D. L. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet 378, 704–712 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Mann, D. L. & Bristow, M. R. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111, 2837–2849 (2005).
  Article PubMed Google Scholar
• Toischer, K. et al. Differential cardiac remodeling in preload versus afterload. Circulation 122, 993–1003 (2010).
  Article PubMed PubMed Central Google Scholar
• van Berlo, J. H., Maillet, M. & Molkentin, J. D. Signaling effectors underlying pathologic growth and remodeling of the heart. J. Clin. Invest. 123, 37–45 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Lowes, B. D. et al. Changes in gene expression in the intact human heart. Downregulation of alpha-Myosin heavy chain in hypertrophied, failing ventricular myocardium. J. Clin. Invest. 100, 2315–2324 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Kostin, S., Hein, S., Arnon, E., Scholz, D. & Schaper, J. The cytoskeleton and related proteins in the human failing heart. Heart Fail. Rev. 5, 271–280 (2000).
  Article CAS PubMed Google Scholar
• Hein, S., Kostin, S., Heling, A., Maeno, Y. & Schaper, J. The role of the cytoskeleton in heart failure. Cardiovasc. Res. 45, 273–278 (2000).
  CAS PubMed Google Scholar
• Rockman, H. A., Koch, W. J. & Lefkowitz, R. J. Seven-transmembrane-spanning receptors and heart function. Nature 415, 206–212 (2002).
  Article CAS PubMed Google Scholar
• Lymperopoulos, A., Rengo, G. & Koch, W. J. Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ. Res. 113, 739–753 (2013).
  Article CAS PubMed Google Scholar
• Feldman, D. S., Carnes, C. A., Abraham, W. T. & Bristow, M. R. Mechanisms of disease: beta-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failure. Nat. Clin. Pract. Cardiovasc. Med. 2, 475–483 (2005).
  Article CAS PubMed Google Scholar
• Port, J. D. & Bristow, M. R. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J. Mol. Cell Cardiol. 33, 887–905 (2001).
  Article CAS PubMed Google Scholar
• Bristow, M. R. et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N. Engl. J. Med. 307, 205–211 (1982).
  Article CAS PubMed Google Scholar
• Bristow, M. R. et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ. Res. 59, 297–309 (1986).
  Article CAS PubMed Google Scholar
• Reiter, E. & Lefkowitz, R. J. GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol. Metab. 17, 159–165 (2006).
  Article CAS PubMed Google Scholar
• Ungerer, M., Bohm, M., Elce, J. S., Erdmann, E. & Lohse, M. J. Altered expression of beta-adrenergic receptor kinase and beta1-adrenergic receptors in the failing human heart. Circulation 87, 454–463 (1993).
  Article CAS PubMed Google Scholar
• Iaccarino, G., Tomhave, E. D., Lefkowitz, R. J. & Koch, W. J. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. Circulation 98, 1783–1789 (1998).
  Article CAS PubMed Google Scholar
• Rockman, H. A. et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc. Natl Acad. Sci. USA 95, 7000–7005 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Rengo, G. et al. Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation 119, 89–98 (2009).
  Article CAS PubMed Google Scholar
• Raake, P. W. et al. AAV6.betaARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model. Eur. Heart J. 34, 1437–1447 (2013).
  Article CAS PubMed Google Scholar
• Harding, V. B., Jones, L. R., Lefkowitz, R. J., Koch, W. J. & Rockman, H. A. Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure. Proc. Natl Acad. Sci. USA 98, 5809–5814 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Rajabi, M., Kassiotis, C., Razeghi, P. & Taegtmeyer, H. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev. 12, 331–343 (2007).
  Article CAS PubMed Google Scholar
• Lowes, B. D. et al. Myocardial gene expression in dilated cardiomyopathy treated with beta- blocking agents. N. Engl. J. Med. 346, 1357–1365 (2002).
  Article CAS PubMed Google Scholar
• Brooks, W. W. et al. Captopril modifies gene expression in hypertrophied and failing hearts of aged spontaneously hypertensive rats. Hypertension 30, 1362–1368 (1997).
  Article CAS PubMed Google Scholar
• Wang, J., Guo, X. & Dhalla, N. S. Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan. Biochim. Biophys. Acta 1690, 177–184 (2004).
  Article CAS PubMed Google Scholar
• Marks, A. R. Calcium cycling proteins and heart failure: mechanisms and therapeutics. J. Clin. Invest. 123, 46–52 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Marx, S. O. et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101, 365–376 (2000).
  Article CAS PubMed Google Scholar
• Arai, M., Alpert, N. R., MacLennan, D. H., Barton, P. & Periasamy, M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. Circ. Res. 72, 463–469 (1993).
  Article CAS PubMed Google Scholar
• Hasenfuss, G. et al. Relation between myocardial function and expression of sarcoplasmic reticulum ca2+-ATPase in failing and nonfailing human myocardium. Circ. Res. 75, 434–442 (1994).
  Article CAS PubMed Google Scholar
• Reiken, S. et al. Beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure. Circulation 104, 2843–2848 (2001).
  Article CAS PubMed Google Scholar
• Reiken, S. et al. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 107, 2459–2466 (2003).
  Article CAS PubMed Google Scholar
• Mann, D. L. Left ventricular size and shape: determinants of mechanical signal transduction pathways. Heart Fail. Rev. 10, 95–100 (2005).
  Article PubMed Google Scholar
• Guerra, S. et al. Myocyte death in the failing human heart is gender dependent. Circ. Res. 85, 856–866 (1999).
  Article CAS PubMed Google Scholar
• Kostin, S. et al. Myocytes die by multiple mechanisms in failing human hearts. Circ. Res. 92, 715–724 (2003).
  Article CAS PubMed Google Scholar
• Whelan, R. S., Kaplinskiy, V. & Kitsis, R. N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu. Rev. Physiol. 72, 19–44 (2010).
  Article CAS PubMed Google Scholar
• Kroemer, G. et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16, 3–11 (2009).
  Article CAS PubMed Google Scholar
• Tan, L. B., Jalil, J. E., Pick, R., Janicki, J. S. & Weber, K. T. Cardiac myocyte necrosis induced by angiotensin II. Circ. Res. 69, 1185–1195 (1991).
  Article CAS PubMed Google Scholar
• Todd, G. L., Baroldi, G., Pieper, G. M., Clayton, F. C. & Eliot, R. S. Experimental catecholamine-induced myocardial ncrosis I. Morphology, quantification and regional distribution of acute contraction band lesions. J. Mol. Cell. Cardiol. 17, 317–338 (1985).
  Article CAS PubMed Google Scholar
• Zhang, W. et al. Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo. J. Am. Heart Assoc. 4, e001993 (2015).
  PubMed PubMed Central Google Scholar
• Epelman, S., Liu, P. P. & Mann, D. L. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat. Rev. Immunol. 15, 117–129 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Olivetti, G. et al. Apoptosis in the failing human heart. N. Engl. J. Med. 336, 1131–1141 (1997).
  Article CAS PubMed Google Scholar
• Saraste, A. et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur. J. Clin. Invest. 29, 380–386 (1999).
  Article CAS PubMed Google Scholar
• Wencker, D. et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 111, 1497–1504 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Communal, C., Singh, K., Sawyer, D. B. & Colucci, W. S. Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100, 2210–2212 (1999).
  Article CAS PubMed Google Scholar
• Haudek, S. B., Taffet, G. E., Schneider, M. D. & Mann, D. L. TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J. Clin. Invest. 117, 2692–2701 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Kajstura, J. et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J. Mol. Cell Cardiol. 29, 859–870 (1997).
  Article CAS PubMed Google Scholar
• Kroemer, G., Marino, G. & Levine, B. Autophagy and the integrated stress response. Mol. Cell 40, 280–293 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Lavandero, S., Chiong, M., Rothermel, B. A. & Hill, J. A. Autophagy in cardiovascular biology. J. Clin. Invest. 125, 55–64 (2015).
  Article PubMed PubMed Central Google Scholar
• Ma, X. et al. Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation 125, 3170–3181 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kong, P., Christia, P. & Frangogiannis, N. G. The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 71, 549–574 (2014).
  Article CAS PubMed Google Scholar
• Davis, J. & Molkentin, J. D. Myofibroblasts: trust your heart and let fate decide. J. Mol. Cell Cardiol. 70, 9–18 (2014).
  Article CAS PubMed Google Scholar
• Hartupee, J. & Mann, D. L. Role of inflammatory cells in fibroblast activation. J. Mol. Cell Cardiol 93, 143–148 (2016).
  Article CAS PubMed Google Scholar
• Schorb, W. et al. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ. Res. 72, 1245–1254 (1993).
  Article CAS PubMed Google Scholar
• Sadoshima, J. I. & Izumo, S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ. Res. 73, 413–423 (1993).
  Article CAS PubMed Google Scholar
• Brilla, C. G., Funck, R. C. & Rupp, H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 102, 1388–1393 (2000).
  Article CAS PubMed Google Scholar
• Izawa, H. et al. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 112, 2940–2945 (2005).
  Article CAS PubMed Google Scholar
• Zannad, F., Alla, F., Dousset, B., Perez, A. & Pitt, B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 102, 2700–2706 (2000).
  Article CAS PubMed Google Scholar
• Li, Y. Y., Feldman, A. M., Sun, Y. & McTiernan, C. F. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 98, 1728–1734 (1998).
  Article CAS PubMed Google Scholar
• Creemers, E. E. et al. Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am. J. Physiol. Heart Circ. Physiol. 284, H364–H371 (2003).
  Article CAS PubMed Google Scholar
• Ducharme, A. et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest. 106, 55–62 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, H. E. et al. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J. Clin. Invest. 106, 857–866 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Peterson, J. T. et al. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 103, 2303–2309 (2001).
  Article CAS PubMed Google Scholar
• Koitabashi, N. & Kass, D. A. Reverse remodeling in heart failure—mechanisms and therapeutic opportunities. Nat. Rev. Cardiol. 9, 147–157 (2012).
  Article CAS Google Scholar
• Mann, D. L., Barger, P. M. & Burkhoff, D. Myocardial recovery: myth, magic or molecular target? J. Am. Coll. Cardiol. 60, 2465–2472 (2012).
  Article PubMed PubMed Central Google Scholar